🇺🇸 FDA
Pipeline program

BRL-101

2024-BRL-101-SCD-01

Unknown small_molecule active

Quick answer

BRL-101 for Sickle Cell Disease is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Sickle Cell Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials